About Julian Chick
Form D filings for Mid-Atlantic BioTherapeutics in 2024 list Julian Chick as director.
Julian Chick first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Julian Chick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Julian Chick works with at each company, as listed on that company's latest Form D.
Mid-Atlantic BioTherapeutics, Inc. · Form D, Sep 30, 2024
DH
David Horn
Chief Executive Officer and director
MG
Michael Goldblatt
Director
AK
Andrew Katz
Director
DJ
David Jobes
President and director
JG
Jean Pierre Gagnon
Director